Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions

被引:61
作者
Blackwell, JE
Dagia, NM
Dickerson, JB
Berg, EL
Goetz, DJ [1 ]
机构
[1] Ohio Univ, Dept Chem Engn, Stocker Ctr 172, Athens, OH 45701 USA
[2] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA
[3] Prot Design Labs Inc, Fremont, CA USA
基金
美国国家科学基金会;
关键词
endothelium; drug delivery; nanospheres; leukocyte; atherosclerosis; targeting;
D O I
10.1114/1.1376697
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The heterogeneous distribution of endothelial cell adhesion molecules (ECAMs) on the lumenal surface of vascular endothelium provides an opportunity to deliver drugs to select tissues. The targeting could be achieved by using carriers whose outer surface has a Ligand for a selectively expressed ECAM. The carriers would interact with the endothelium in a fluid dynamic environment and in many of these schemes nanoparticles would be used. It is unclear what role various parameters (e.g., ligand-ECAM chemistry, fluid shear) will have on the adhesion of the nanoparticles to the endothelium. To facilitate studies in this area, we have developed a prototypical in vitro model that allows investigation of nanoparticle adhesion. We coated polystyrene nanospheres with a humanized mAb (HuEP5C7.g2) that recognizes the ECAMs E- and P-selectin. Adhesion assays revealed that HuEP5C7.g2 nanospheres exhibit augmented, specific adhesion to selectin presenting cellular monolayers and that the adhesion can be affected by the fluid shear. These results; (i) strongly suggest that HuEP5C7.g2 could be used to target nanoparticles to selectin presenting endothelium; (ii) demonstrate that fluid shear can affect nanoparticle adhesion; and (iii) define a system which can be used to study the effects of various system parameters on nanoparticle adhesion. (C) 2001 Biomedical Engineering Society.
引用
收藏
页码:523 / 533
页数:11
相关论文
共 46 条
[1]   LIFETIME OF THE P-SELECTIN-CARBOHYDRATE BOND AND ITS RESPONSE TO TENSILE FORCE IN HYDRODYNAMIC FLOW [J].
ALON, R ;
HAMMER, DA ;
SPRINGER, TA .
NATURE, 1995, 374 (6522) :539-542
[2]  
Anderson WF, 1998, NATURE, V392, P25
[3]   Targetability of novel immunoliposomes prepared by a new antibody conjugation technique [J].
Bendas, G ;
Krause, A ;
Bakowsky, U ;
Vogel, J ;
Rothe, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 181 (01) :79-93
[4]  
Bendas G, 1998, Pharm Acta Helv, V73, P19, DOI 10.1016/S0031-6865(97)00043-5
[5]   IDENTIFICATION OF AN INDUCIBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE [J].
BEVILACQUA, MP ;
POBER, JS ;
MENDRICK, DL ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9238-9242
[6]   ADHESION MOLECULES - A NEW TARGET FOR IMMUNOLIPOSOME-MEDIATED DRUG-DELIVERY [J].
BLOEMEN, PGM ;
HENRICKS, PAJ ;
VANBLOOIS, L ;
VANDENTWEEL, MC ;
BLOEM, AC ;
NIJKAMP, FP ;
CROMMELIN, DJA ;
STORM, G .
FEBS LETTERS, 1995, 357 (02) :140-144
[7]   THE BLOOD-BRAIN-BARRIER [J].
BRADBURY, MWB .
EXPERIMENTAL PHYSIOLOGY, 1993, 78 (04) :453-472
[8]   RECEPTOR-MEDIATED ADHESION PHENOMENA - MODEL STUDIES WITH THE RADIAL-FLOW DETACHMENT ASSAY [J].
COZENSROBERTS, C ;
QUINN, JA ;
LAUFFENBURGER, DA .
BIOPHYSICAL JOURNAL, 1990, 58 (01) :107-125
[9]   CD11b/CD18-coated microspheres attach to E-selectin under flow [J].
Crutchfield, KL ;
Patil, VRS ;
Campbell, CJ ;
Parkos, CA ;
Allport, JR ;
Goetz, DJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (02) :196-205
[10]   ENDOTHELIAL EXPRESSION OF A MONONUCLEAR LEUKOCYTE ADHESION MOLECULE DURING ATHEROGENESIS [J].
CYBULSKY, MI ;
GIMBRONE, MA .
SCIENCE, 1991, 251 (4995) :788-791